Purification of ornithine decarboxylase from kidneys of androgen-treated mice.
Purification of ornithine decarboxylase from kidneys of androgen-treated mice.
复制标题
从雄激素处理小鼠的肾脏中纯化鸟氨酸脱羧酶。
DOI:
10.1021/bi00257a023
复制
发表时间:
1982
期刊:
影响因子:
2.9
通讯作者:
Pegg,AE
中科院分区:
文献类型:
--
作者:
Seely,JE;Pösö,H;Pegg,AE
James E. Seely,* Hannu Poso, § and Anthony E. Pegg* abstract: Ornithine decarboxylase has been purified to homogeneity from kidneys of androgen-treated mice. Such kidneys have an enzyme content 2 orders of magnitude greater than thatof other mammalian tissues such as induced rat liver, and only a 10350-fold purification was needed for purification. The enzyme preparation gave a single band on isoelectric focusing and on polyacrylamide gel electrophoresis under native and denaturing conditions. These bands corresponded to the enzyme activity and to the migration of ornithine de-carboxylase labeled by reaction with a-(difluoromethyl)[5-14C] ornithine, a specific inhibitor. The enzyme has a Mr of about 100000 and is a dimer of subunit Mr 53 000. The Km for L-ornithine was 75/iM and for pyridoxal phosphate, 0.3^ M. The preparation had a specific activityof 50^ mol of C02 produced min'1 mg'1 and bound a stoichiometric amount of the irreversible inhibitor, a-(difluoromethyl) ornithine (one molecule per subunit). The purified enzyme was unstable even in the presence of 2.5 mM dithiothreitol and 40 juM pyridoxal phosphate unless 0.02% Brij 35 was added. In thepresence of this detergent, the enzyme could be stored with little loss of activity. ere hasbeen considerableinterest in the enzyme ornithine decarboxylase (EC 4.1. 1.17) for a number of reasons [reviewed by Morris & Fillingame (1974), Janne et al.(1978), Canellakis et al.(1979), McCann (1980), Russell (1980), and Pegg & Williams-Ashman (1981)]. In mammalian cells, this enzyme provides the only source of putrescine, a precursor of the polyamines. Its activity increases veryrapidly in response to a wide variety of trophic stimuli, and it appears to have the most rapid rate of protein synthesis and degradation among mammalian enzymes. Its activity may also be regulated by the level of a macromolecular inhibitor (Canellakis et al., 1978) and a variety of posttranslational modifications (Mitchell, 1981; Russell, 1981; Atmar & Kuehn, 1981). The enzyme is the target for potentially useful chemotherapeutic agents